Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Renata Lo Prete - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Journalist and  Anchor, G1

Renata Lo Prete

Verified

Journalist and Anchor, G1

São Paulo

Beats

Primary beats

HealthBrazil

Secondary beats

DiningTheatreCongressDanceSocial JusticeArt HistoryBeauty IndustryNewsMental HealthHealthcareTechnologyDigital CamerasTennisLifestyleTravelHealthcare SystemsSwimming

Biography

Final Covers

Doesn’t Cover

Other than the above. I do not write about other topics.

Journalist Type

Anchor,Journalist

Seniority Positions

Mid

Industries

Online Media

Medium Formats

Radio,Television

Content

Total articles 640

  • Available on paid plans

    Renata Lo Prete: Zambelli perde importância e quem ganha mais uma dor de cabeça é Bolsonaro

    By Renata Lo Prete Verified

    Aug. 03, 2023

  • Available on paid plans

    Renata Lo Prete: eleições municipais serão o 1º termômetro de Bolsonaro inelegível como cabo eleitoral

    By Renata Lo Prete Verified

    Jun. 30, 2023

  • Available on paid plans

    Renata Lo Prete: Zambelli perde importância e quem ganha mais uma dor de cabeça é Bolsonaro

    By Renata Lo Prete Verified

    Aug. 03, 2023

As seen in

Cbn Radio,O Globo,Isso É Fantástico,G1

Company Info

G1

G1 Therapeutics, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina. Founded in 2008, it focuses on developing small molecule therapies for cancer treatment. The company aims to improve patient outcomes by targeting cellular pathways involved in cancer progression. G1 Therapeutics became a subsidiary of Pharmacosmos A/S in September 2024. The company's flagship product, COSELA (trilaciclib), is an FDA-approved drug that protects bone marrow from chemotherapy damage. It is administered intravenously before chemotherapy to enhance patient safety. G1 Therapeutics also has a pipeline that includes lerociclib, a CDK4/6 inhibitor, and other investigational compounds aimed at cancer treatment. The company collaborates with organizations like GeneCentric Therapeutics and AstraZeneca to advance its research and clinical trials.

São Paulo, , Brazil

+1 919-213-9835

Founded: 2008


Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved